DUBLIN–(BUSINESS WIRE)–The “Erythropoietin Medicine Market: International Trade Developments, Share, Dimension, Development, Alternative and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s providing.
The worldwide erythropoietin medication market dimension reached US$ 9.8 Billion in 2021. Trying ahead, the writer expects the market to achieve US$ 13.8 Billion by 2027, exhibiting a CAGR of 5.87% throughout 2021-2027.
Firms Talked about
- Amgen Inc.
- Biocon Restricted
- Dr. Reddy’s Laboratories Ltd.
- F. Hoffmann-La Roche AG
- Intas Prescribed drugs Ltd.
- Johnson & Johnson
- LG Chem Ltd.
- Pfizer Inc.
- Solar Pharmaceutical Industries Restricted
- Teva Pharmaceutical Industries Ltd.
Maintaining in thoughts the uncertainties of COVID-19, we’re constantly monitoring and evaluating the direct in addition to the oblique affect of the pandemic on totally different finish use sectors. These insights are included within the report as a serious market contributor.
Erythropoietin (EPO) is a hormone produced by kidneys to stimulate the manufacturing of purple blood cells (RBCs). Its deficiency can result in low hemoglobin ranges and numerous medical situations.
In consequence, there’s a rise within the demand for EPO medication, also referred to as EPO stimulating brokers (ESAs), that are produced synthetically utilizing recombinant deoxyribonucleic acid (DNA) expertise. They’re often administered by way of the intramuscular route and launched into the bloodstream to stimulate RBC manufacturing.
At current, they’re accessible in numerous sorts with totally different dosage schedules and modes of supply. EPO medication are usually given to sufferers present process chemotherapy, continual renal failure, and antiviral drug remedy or at excessive threat for perioperative blood loss from surgical procedures.
People who’ve anemia on account of most cancers, prematurity, and continual kidney illness (CKD) are often on the threat of low hemoglobin ranges. This represents one of many key elements positively influencing the gross sales of EPO medication worldwide. As well as, they’re used to deal with zidovudine amongst sufferers with human immunodeficiency virus (HIV) an infection.
Furthermore, the rising want for surgical interventions on account of the rising growing older inhabitants throughout the globe is catalyzing the usage of EOP medication to attenuate allogeneic blood transfusions after surgical procedures. Moreover, the escalating demand for minimally invasive (MI) procedures is bolstering the expansion of the market.
Aside from this, the rising use of EPO medication as a novel therapeutic agent in analysis settings is projected to develop their functions in treating numerous ailments. These ailments usually embody spinal cord injury (SCI), melancholy, diabetes, acute kidney injury (AKI), recombinant remedy for sufferers with coronary heart failure, and a neuroprotective agent in ischemic stroke.
Key Market Segmentation:
The writer gives an evaluation of the important thing tendencies in every sub-segment of the worldwide erythropoietin medication market report, together with forecasts on the international, regional and nation stage from 2022-2027. Our report has categorized the market based mostly on drug class, product kind, software and finish person.
Breakup by Drug Class:
Breakup by Product Sort:
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
Breakup by Utility:
- Hematology
- Kidney Dysfunction
- Most cancers
- Others
Breakup by Finish Person:
- Hospitals
- Homecare
- Specialty Clinics
- Others
Breakup by Area:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Center East and Africa
Key Questions Answered in This Report:
- How has the worldwide erythropoietin medication market carried out up to now and the way will it carry out within the coming years?
- What has been the affect of COVID-19 on the worldwide erythropoietin medication market?
- What are the important thing regional markets?
- What’s the breakup of the market based mostly on the drug class?
- What’s the breakup of the market based mostly on the product kind?
- What’s the breakup of the market based mostly on the appliance?
- What’s the breakup of the market based mostly on the top person?
- What are the varied phases within the worth chain of the trade?
- What are the important thing driving elements and challenges within the trade?
- What’s the construction of the worldwide erythropoietin medication market and who’re the important thing gamers?
- What’s the diploma of competitors within the trade?
For extra details about this report go to https://www.researchandmarkets.com/r/4f4slq
Discussion about this post